Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Immunotherapy Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Monoclonal Antibodies
1.2.3 Adult Vaccines
1.2.4 Checkpoint Inhibitors
1.2.5 Interferons Alpha & Beta
1.2.6 Interleukins
1.2.7 Others
1.3 Market by Application
1.3.1 Global Immunotherapy Drugs Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Cancer
1.3.3 Autoimmune & Inflammatory Diseases
1.3.4 Infectious Diseases
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Immunotherapy Drugs Market Perspective (2018-2033)
2.2 Immunotherapy Drugs Growth Trends by Region
2.2.1 Global Immunotherapy Drugs Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Immunotherapy Drugs Historic Market Size by Region (2018-2023)
2.2.3 Immunotherapy Drugs Forecasted Market Size by Region (2024-2033)
2.3 Immunotherapy Drugs Market Dynamics
2.3.1 Immunotherapy Drugs Industry Trends
2.3.2 Immunotherapy Drugs Market Drivers
2.3.3 Immunotherapy Drugs Market Challenges
2.3.4 Immunotherapy Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Immunotherapy Drugs Players by Revenue
3.1.1 Global Top Immunotherapy Drugs Players by Revenue (2018-2023)
3.1.2 Global Immunotherapy Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Immunotherapy Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Immunotherapy Drugs Revenue
3.4 Global Immunotherapy Drugs Market Concentration Ratio
3.4.1 Global Immunotherapy Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Immunotherapy Drugs Revenue in 2022
3.5 Immunotherapy Drugs Key Players Head office and Area Served
3.6 Key Players Immunotherapy Drugs Product Solution and Service
3.7 Date of Enter into Immunotherapy Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Immunotherapy Drugs Breakdown Data by Type
4.1 Global Immunotherapy Drugs Historic Market Size by Type (2018-2023)
4.2 Global Immunotherapy Drugs Forecasted Market Size by Type (2024-2033)
5 Immunotherapy Drugs Breakdown Data by Application
5.1 Global Immunotherapy Drugs Historic Market Size by Application (2018-2023)
5.2 Global Immunotherapy Drugs Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Immunotherapy Drugs Market Size (2018-2033)
6.2 North America Immunotherapy Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Immunotherapy Drugs Market Size by Country (2018-2023)
6.4 North America Immunotherapy Drugs Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Immunotherapy Drugs Market Size (2018-2033)
7.2 Europe Immunotherapy Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Immunotherapy Drugs Market Size by Country (2018-2023)
7.4 Europe Immunotherapy Drugs Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Immunotherapy Drugs Market Size (2018-2033)
8.2 Asia-Pacific Immunotherapy Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Immunotherapy Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Immunotherapy Drugs Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Immunotherapy Drugs Market Size (2018-2033)
9.2 Latin America Immunotherapy Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Immunotherapy Drugs Market Size by Country (2018-2023)
9.4 Latin America Immunotherapy Drugs Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Immunotherapy Drugs Market Size (2018-2033)
10.2 Middle East & Africa Immunotherapy Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Immunotherapy Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Immunotherapy Drugs Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Immunotherapy Drugs Introduction
11.1.4 Roche Revenue in Immunotherapy Drugs Business (2018-2023)
11.1.5 Roche Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Immunotherapy Drugs Introduction
11.2.4 Merck Revenue in Immunotherapy Drugs Business (2018-2023)
11.2.5 Merck Recent Development
11.3 Novartis
11.3.1 Novartis Company Detail
11.3.2 Novartis Business Overview
11.3.3 Novartis Immunotherapy Drugs Introduction
11.3.4 Novartis Revenue in Immunotherapy Drugs Business (2018-2023)
11.3.5 Novartis Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Detail
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Immunotherapy Drugs Introduction
11.4.4 Johnson & Johnson Revenue in Immunotherapy Drugs Business (2018-2023)
11.4.5 Johnson & Johnson Recent Development
11.5 Glaxosmithkline
11.5.1 Glaxosmithkline Company Detail
11.5.2 Glaxosmithkline Business Overview
11.5.3 Glaxosmithkline Immunotherapy Drugs Introduction
11.5.4 Glaxosmithkline Revenue in Immunotherapy Drugs Business (2018-2023)
11.5.5 Glaxosmithkline Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Immunotherapy Drugs Introduction
11.6.4 Amgen Revenue in Immunotherapy Drugs Business (2018-2023)
11.6.5 Amgen Recent Development
11.7 Abbvie
11.7.1 Abbvie Company Detail
11.7.2 Abbvie Business Overview
11.7.3 Abbvie Immunotherapy Drugs Introduction
11.7.4 Abbvie Revenue in Immunotherapy Drugs Business (2018-2023)
11.7.5 Abbvie Recent Development
11.8 Astrazeneca
11.8.1 Astrazeneca Company Detail
11.8.2 Astrazeneca Business Overview
11.8.3 Astrazeneca Immunotherapy Drugs Introduction
11.8.4 Astrazeneca Revenue in Immunotherapy Drugs Business (2018-2023)
11.8.5 Astrazeneca Recent Development
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Detail
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Immunotherapy Drugs Introduction
11.9.4 Bristol-Myers Squibb Revenue in Immunotherapy Drugs Business (2018-2023)
11.9.5 Bristol-Myers Squibb Recent Development
11.10 ELI Lilly
11.10.1 ELI Lilly Company Detail
11.10.2 ELI Lilly Business Overview
11.10.3 ELI Lilly Immunotherapy Drugs Introduction
11.10.4 ELI Lilly Revenue in Immunotherapy Drugs Business (2018-2023)
11.10.5 ELI Lilly Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Immunotherapy Drugs Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Adult Vaccines
Table 4. Key Players of Checkpoint Inhibitors
Table 5. Key Players of Interferons Alpha & Beta
Table 6. Key Players of Interleukins
Table 7. Key Players of Others
Table 8. Global Immunotherapy Drugs Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Immunotherapy Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 10. Global Immunotherapy Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 11. Global Immunotherapy Drugs Market Share by Region (2018-2023)
Table 12. Global Immunotherapy Drugs Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 13. Global Immunotherapy Drugs Market Share by Region (2024-2033)
Table 14. Immunotherapy Drugs Market Trends
Table 15. Immunotherapy Drugs Market Drivers
Table 16. Immunotherapy Drugs Market Challenges
Table 17. Immunotherapy Drugs Market Restraints
Table 18. Global Immunotherapy Drugs Revenue by Players (2018-2023) & (US$ Million)
Table 19. Global Immunotherapy Drugs Market Share by Players (2018-2023)
Table 20. Global Top Immunotherapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunotherapy Drugs as of 2022)
Table 21. Ranking of Global Top Immunotherapy Drugs Companies by Revenue (US$ Million) in 2022
Table 22. Global 5 Largest Players Market Share by Immunotherapy Drugs Revenue (CR5 and HHI) & (2018-2023)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Immunotherapy Drugs Product Solution and Service
Table 25. Date of Enter into Immunotherapy Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Immunotherapy Drugs Market Size by Type (2018-2023) & (US$ Million)
Table 28. Global Immunotherapy Drugs Revenue Market Share by Type (2018-2023)
Table 29. Global Immunotherapy Drugs Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 30. Global Immunotherapy Drugs Revenue Market Share by Type (2024-2033)
Table 31. Global Immunotherapy Drugs Market Size by Application (2018-2023) & (US$ Million)
Table 32. Global Immunotherapy Drugs Revenue Market Share by Application (2018-2023)
Table 33. Global Immunotherapy Drugs Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 34. Global Immunotherapy Drugs Revenue Market Share by Application (2024-2033)
Table 35. North America Immunotherapy Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America Immunotherapy Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Immunotherapy Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe Immunotherapy Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 39. Europe Immunotherapy Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 40. Europe Immunotherapy Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 41. Asia-Pacific Immunotherapy Drugs Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 42. Asia-Pacific Immunotherapy Drugs Market Size by Region (2018-2023) & (US$ Million)
Table 43. Asia-Pacific Immunotherapy Drugs Market Size by Region (2024-2033) & (US$ Million)
Table 44. Latin America Immunotherapy Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Latin America Immunotherapy Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 46. Latin America Immunotherapy Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 47. Middle East & Africa Immunotherapy Drugs Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 48. Middle East & Africa Immunotherapy Drugs Market Size by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Immunotherapy Drugs Market Size by Country (2024-2033) & (US$ Million)
Table 50. Roche Company Detail
Table 51. Roche Business Overview
Table 52. Roche Immunotherapy Drugs Product
Table 53. Roche Revenue in Immunotherapy Drugs Business (2018-2023) & (US$ Million)
Table 54. Roche Recent Development
Table 55. Merck Company Detail
Table 56. Merck Business Overview
Table 57. Merck Immunotherapy Drugs Product
Table 58. Merck Revenue in Immunotherapy Drugs Business (2018-2023) & (US$ Million)
Table 59. Merck Recent Development
Table 60. Novartis Company Detail
Table 61. Novartis Business Overview
Table 62. Novartis Immunotherapy Drugs Product
Table 63. Novartis Revenue in Immunotherapy Drugs Business (2018-2023) & (US$ Million)
Table 64. Novartis Recent Development
Table 65. Johnson & Johnson Company Detail
Table 66. Johnson & Johnson Business Overview
Table 67. Johnson & Johnson Immunotherapy Drugs Product
Table 68. Johnson & Johnson Revenue in Immunotherapy Drugs Business (2018-2023) & (US$ Million)
Table 69. Johnson & Johnson Recent Development
Table 70. Glaxosmithkline Company Detail
Table 71. Glaxosmithkline Business Overview
Table 72. Glaxosmithkline Immunotherapy Drugs Product
Table 73. Glaxosmithkline Revenue in Immunotherapy Drugs Business (2018-2023) & (US$ Million)
Table 74. Glaxosmithkline Recent Development
Table 75. Amgen Company Detail
Table 76. Amgen Business Overview
Table 77. Amgen Immunotherapy Drugs Product
Table 78. Amgen Revenue in Immunotherapy Drugs Business (2018-2023) & (US$ Million)
Table 79. Amgen Recent Development
Table 80. Abbvie Company Detail
Table 81. Abbvie Business Overview
Table 82. Abbvie Immunotherapy Drugs Product
Table 83. Abbvie Revenue in Immunotherapy Drugs Business (2018-2023) & (US$ Million)
Table 84. Abbvie Recent Development
Table 85. Astrazeneca Company Detail
Table 86. Astrazeneca Business Overview
Table 87. Astrazeneca Immunotherapy Drugs Product
Table 88. Astrazeneca Revenue in Immunotherapy Drugs Business (2018-2023) & (US$ Million)
Table 89. Astrazeneca Recent Development
Table 90. Bristol-Myers Squibb Company Detail
Table 91. Bristol-Myers Squibb Business Overview
Table 92. Bristol-Myers Squibb Immunotherapy Drugs Product
Table 93. Bristol-Myers Squibb Revenue in Immunotherapy Drugs Business (2018-2023) & (US$ Million)
Table 94. Bristol-Myers Squibb Recent Development
Table 95. ELI Lilly Company Detail
Table 96. ELI Lilly Business Overview
Table 97. ELI Lilly Immunotherapy Drugs Product
Table 98. ELI Lilly Revenue in Immunotherapy Drugs Business (2018-2023) & (US$ Million)
Table 99. ELI Lilly Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Immunotherapy Drugs Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Immunotherapy Drugs Market Share by Type: 2022 VS 2033
Figure 3. Monoclonal Antibodies Features
Figure 4. Adult Vaccines Features
Figure 5. Checkpoint Inhibitors Features
Figure 6. Interferons Alpha & Beta Features
Figure 7. Interleukins Features
Figure 8. Others Features
Figure 9. Global Immunotherapy Drugs Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 10. Global Immunotherapy Drugs Market Share by Application: 2022 VS 2033
Figure 11. Cancer Case Studies
Figure 12. Autoimmune & Inflammatory Diseases Case Studies
Figure 13. Infectious Diseases Case Studies
Figure 14. Others Case Studies
Figure 15. Immunotherapy Drugs Report Years Considered
Figure 16. Global Immunotherapy Drugs Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 17. Global Immunotherapy Drugs Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 18. Global Immunotherapy Drugs Market Share by Region: 2022 VS 2033
Figure 19. Global Immunotherapy Drugs Market Share by Players in 2022
Figure 20. Global Top Immunotherapy Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunotherapy Drugs as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Immunotherapy Drugs Revenue in 2022
Figure 22. North America Immunotherapy Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. North America Immunotherapy Drugs Market Share by Country (2018-2033)
Figure 24. United States Immunotherapy Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada Immunotherapy Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe Immunotherapy Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe Immunotherapy Drugs Market Share by Country (2018-2033)
Figure 28. Germany Immunotherapy Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Immunotherapy Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Immunotherapy Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Immunotherapy Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Immunotherapy Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Immunotherapy Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Asia-Pacific Immunotherapy Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Asia-Pacific Immunotherapy Drugs Market Share by Region (2018-2033)
Figure 36. China Immunotherapy Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Japan Immunotherapy Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. South Korea Immunotherapy Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Southeast Asia Immunotherapy Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. India Immunotherapy Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Australia Immunotherapy Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Latin America Immunotherapy Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Latin America Immunotherapy Drugs Market Share by Country (2018-2033)
Figure 44. Mexico Immunotherapy Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Brazil Immunotherapy Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Middle East & Africa Immunotherapy Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East & Africa Immunotherapy Drugs Market Share by Country (2018-2033)
Figure 48. Turkey Immunotherapy Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Saudi Arabia Immunotherapy Drugs Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Roche Revenue Growth Rate in Immunotherapy Drugs Business (2018-2023)
Figure 51. Merck Revenue Growth Rate in Immunotherapy Drugs Business (2018-2023)
Figure 52. Novartis Revenue Growth Rate in Immunotherapy Drugs Business (2018-2023)
Figure 53. Johnson & Johnson Revenue Growth Rate in Immunotherapy Drugs Business (2018-2023)
Figure 54. Glaxosmithkline Revenue Growth Rate in Immunotherapy Drugs Business (2018-2023)
Figure 55. Amgen Revenue Growth Rate in Immunotherapy Drugs Business (2018-2023)
Figure 56. Abbvie Revenue Growth Rate in Immunotherapy Drugs Business (2018-2023)
Figure 57. Astrazeneca Revenue Growth Rate in Immunotherapy Drugs Business (2018-2023)
Figure 58. Bristol-Myers Squibb Revenue Growth Rate in Immunotherapy Drugs Business (2018-2023)
Figure 59. ELI Lilly Revenue Growth Rate in Immunotherapy Drugs Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed